Dr. Walker co-founded Aclaris and has served as President and Chief Executive Officer and a member of the board of directors since its inception in July 2012. He is a board-certified dermatologist and serial entrepreneur with over 20 years of experience in the life science industry. He began his pharmaceutical industry career at Johnson & Johnson. Dr. Walker co-founded NeXeption, LLC, a biopharmaceutical assets management company, in 2012, and its affiliated companies. Prior to Aclaris, he co-founded and served as President and Chief Executive Officer and a member of the board of directors of Vicept Therapeutics, Inc., a dermatology-focused specialty pharmaceutical company, from 2009 until its acquisition by Allergan, Inc. in 2011. Previously, Dr. Walker co-founded and led a number of life science companies, including Octagon Research Solutions, Inc., a software and services provider to biopharmaceutical companies (acquired by Accenture plc); Trigenesis Therapeutics, Inc., a specialty dermatology company, where he served as Chief Medical Officer (acquired by Dr. Reddy's Laboratories Inc.); and Cutix Inc., a commercial dermatology company. He also co-founded and serves on the board of directors of the Dermatology Summit, Dermatology Innovation Forum, and Advancing Innovation in Dermatology. Dr. Walker is on the board of directors of Aldeyra Therapeutics, Inc., a publicly held biotechnology company, as well as Life Sciences Pennsylvania and several private companies. In 2016, Dr. Walker was awarded the Frank Baldino Bioscience CEO of the Year award and the Ernst & Young Entrepreneur of the Year Greater Philadelphia award. He is a Fellow of the American Academy of Dermatology. He received a Master of Business Administration from The Wharton School of the University of Pennsylvania, a Doctor of Osteopathic Medicine from the Philadelphia College of Osteopathic Medicine, and a Bachelor of Arts in biology from Lehigh University.
What is Neal Walker's net worth?
The estimated net worth of Neal Walker is at least $1.57 million as of March 2nd, 2023. Dr. Walker owns 1,285,188 shares of Aclaris Therapeutics stock worth more than $1,567,929 as of April 24th. This net worth approximation does not reflect any other assets that Dr. Walker may own. Additionally, Dr. Walker receives an annual salary of $955,690.00 as CEO at Aclaris Therapeutics. Learn More about Neal Walker's net worth.
What is Neal Walker's salary?
How do I contact Neal Walker?
Has Neal Walker been buying or selling shares of Aclaris Therapeutics?
Neal Walker has not been actively trading shares of Aclaris Therapeutics during the last quarter. Most recently, Neal Walker sold 29,000 shares of the business's stock in a transaction on Thursday, March 2nd. The shares were sold at an average price of $12.37, for a transaction totalling $358,730.00. Following the completion of the sale, the director now directly owns 1,285,188 shares of the company's stock, valued at $15,897,775.56. Learn More on Neal Walker's trading history.
Who are Aclaris Therapeutics' active insiders?
Are insiders buying or selling shares of Aclaris Therapeutics?
During the last year, Aclaris Therapeutics insiders bought shares 1 times. They purchased a total of 14,705 shares worth more than $99,994.00. During the last year, insiders at the biotechnology company sold shares 3 times. They sold a total of 18,000 shares worth more than $136,080.00. The most recent insider tranaction occured on October, 23rd when insider Joseph Monahan sold 6,000 shares worth more than $30,480.00. Insiders at Aclaris Therapeutics own 5.5% of the company.
Learn More about insider trades at Aclaris Therapeutics. Information on this page was last updated on 10/23/2023.
